191 related articles for article (PubMed ID: 17188741)
1. Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus.
Signorello MG; Viviani GL; Armani U; Cerone R; Minniti G; Piana A; Leoncini G
Thromb Res; 2007; 120(4):607-13. PubMed ID: 17188741
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects.
Mutus B; Rabini RA; Staffolani R; Ricciotti R; Fumelli P; Moretti N; Martarelli D; Mazzanti L
Diabetologia; 2001 Aug; 44(8):979-82. PubMed ID: 11484074
[TBL] [Abstract][Full Text] [Related]
3. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
Cassone Faldetta M; Laurenti O; Desideri G; Bravi MC; De Luca O; Marinucci MC; De Mattia G; Ferri C
Diabetologia; 2002 Aug; 45(8):1120-7. PubMed ID: 12189442
[TBL] [Abstract][Full Text] [Related]
4. Plasma total homocysteine concentrations in obese and non-obese female patients with type 2 diabetes mellitus; its relations with plasma oxidative stress and nitric oxide levels.
Konukoğlu D; Serin O; Turhan MS
Clin Hemorheol Microcirc; 2005; 33(1):41-6. PubMed ID: 16037631
[TBL] [Abstract][Full Text] [Related]
5. Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review.
El Haouari M; Rosado JA
Blood Cells Mol Dis; 2008; 41(1):119-23. PubMed ID: 18387322
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
Dave GS; Kalia K
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
[TBL] [Abstract][Full Text] [Related]
7. Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production.
Schaeffer G; Wascher TC; Kostner GM; Graier WF
Diabetologia; 1999 Feb; 42(2):167-76. PubMed ID: 10064096
[TBL] [Abstract][Full Text] [Related]
8. Elevated nitric oxide levels inhibit malondialdehyde production in patients with diabetes mellitus in Taiwan.
Lee TI; Sun MF; Wen YR; Kuo PL; Liu CF
Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):452-3. PubMed ID: 16314232
[No Abstract] [Full Text] [Related]
9. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
[TBL] [Abstract][Full Text] [Related]
10. Altered myosin light-chain phosphorylation in resting platelets from premenopausal women with diabetes.
Guzmán CB; Walsh M; Reddy V; Donthireddy V; Mahmood F; Bode A; Turner JR; Jacober SJ; Sowers JR
Metabolism; 2001 Feb; 50(2):151-6. PubMed ID: 11229421
[TBL] [Abstract][Full Text] [Related]
11. Effect in vitro of cyclic nucleotides-elevating agents on nitric oxide production by human granulocytes from type 2-diabetic patients.
Nogueira-Machado JA; Lima E Silva FC; Lima E Silva R; Medina LO; Costa DC; Chaves MM
Diabetes Metab; 2002 Feb; 28(1):45-50. PubMed ID: 11938028
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes.
Haidara MA; Mikhailidis DP; Rateb MA; Ahmed ZA; Yassin HZ; Ibrahim IM; Rashed LA
J Diabetes Complications; 2009; 23(2):130-6. PubMed ID: 18436458
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.
Gupta A; Tripathi AK; Tripathi RL; Madhu SV; Banerjee BD
Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between plasma homocysteine and chronic complications in type 2 diabetes mellitus].
Li WP; Li W; Yang T
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):349-50. PubMed ID: 15772011
[TBL] [Abstract][Full Text] [Related]
15. Oxidative status in stable renal transplantation.
Minz M; Heer M; Arora S; Sharma A; Khullar M
Transplant Proc; 2006 Sep; 38(7):2020-1. PubMed ID: 16979986
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in renal transplant patients who develop cardiovascular disease.
El-Ghar SM; Qureshi M; Shoker A; Prasad K
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):203-10. PubMed ID: 17056834
[TBL] [Abstract][Full Text] [Related]
17. Production of superoxide and nitric oxide by granulocytes in non-insulin-dependent diabetic patients with and without diabetic nephropathy.
Kedziora-Kornatowska KZ
IUBMB Life; 1999 Sep; 48(3):359-62. PubMed ID: 10690652
[TBL] [Abstract][Full Text] [Related]
18. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
Ibrahim HA; El-Meligi AA; Abdel-Hamid M; Elhendy A
Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes.
Kassab A; Ajmi T; Issaoui M; Chaeib L; Miled A; Hammami M
Ann Clin Biochem; 2008 Sep; 45(Pt 5):476-80. PubMed ID: 18753419
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ROS production in peripheral blood mononuclear cells from type 2 diabetic patients by autologous plasma depends on Akt/PKB signaling pathway.
Veloso CA; Isoni CA; Borges EA; Mattos RT; Calsolari MR; Reis JS; Bosco AA; Chaves MM; Nogueira-Machado JA
Clin Chim Acta; 2008 Aug; 394(1-2):77-80. PubMed ID: 18455998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
